BreastfeedingPoursuitAllaitNCT05650684
Factors Associated With Continuation of Exclusive Breastfeeding Until the Post-natal Visit
An observational study of Breastfeeding, run by Université de Reims Champagne-Ardenne.
Trial summary
Breastfeeding promotes the health of mother and her child, and remains the reference in terms of infant nutrition. World Health Organization recommends exclusive breastfeeding for the first six months. This recommended duration is not respected in France with a median duration of breastfeeding in France at 3 months. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Breastfeeding
- What is being tested?
- data collection
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2023to 1 Jul 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Adult, Older adult
Study population: Mother initiating exclusive breastfeeding after birth
Who may be able to join
- primiparous and multiparous women
- women who have initiate breastfeeding
- women aged 18 and more
- agreeing to participate in the study
Who cannot join
- women whose newborn has been in intensive care unit
- women with a multiple pregnancy
Trial locations and contacts
No sites are listed yet.
About this study
Breastfeeding promotes the health of mother and her child, and remains the reference in terms of infant nutrition. World Health Organization recommends exclusive breastfeeding for the first six months. This recommended duration is not respected in France with a median duration of breastfeeding in France at 3 months.
Read the detailed description
The aim is to study factors associated with continuation of exclusive breastfeeding until the post-natal visit.
- Conditions
- Breastfeeding
- Being tested
- data collection
- Keywords
- exclusive breastfeeding, postnatal visit, factors associated
- Medical subject headings
- Breast Feeding
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
data collectionOther
continuation of exclusive breastfeeding until the post-natal visit (6 to 8 weeks after birth)
| Study group | Role | What they receive |
|---|---|---|
| "exclusive breastfeeding" group | Women initiating exclusive breastfeeding after birth Receives: Other: data collection |
What is being measured
The primary outcome is the main question the study is designed to answer.
breastfeeding
number of women practicing or not exclusive breastfeeding until postnatal consultation (6 to 8 weeks after birth)
Measured: Day 0
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Dec 2022
- Study start1 Jan 2023 (estimated)
- Primary completion1 Apr 2023 (estimated)
- Study completion1 Jul 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for BreastfeedingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Université de Reims Champagne-Ardenne
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05650684
- Sponsor's protocol ID
- 2022_RIPH_013_Poursuit-Allait
- Acronym
- PoursuitAllait
- Status last verified
- Dec 2022
- First submitted
- 6 Dec 2022
- Last updated
- 16 Dec 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Dec 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Factors Associated With Continuation of Exclusive Breastfeeding Until the Post-natal Visit
- ClinicalTrials.gov ID
- NCT05650684
- Acronym / sponsor ID
- PoursuitAllait / 2022_RIPH_013_Poursuit-Allait
- Conditions
- Breastfeeding
- Keywords
- exclusive breastfeeding, postnatal visit, factors associated
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Université de Reims Champagne-ArdenneUniversity, hospital or other
- Study start
- 1 Jan 2023 (estimated)
- Primary completion
- 1 Apr 2023 (estimated)
- Study completion
- 1 Jul 2023 (estimated)
- First posted
- 14 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Breastfeeding promotes the health of mother and her child, and remains the reference in terms of infant nutrition. World Health Organization recommends exclusive breastfeeding for the first six months. This recommended duration is not respected in France with a median duration of breastfeeding in France at 3 months.
Detailed description
The aim is to study factors associated with continuation of exclusive breastfeeding until the post-natal visit.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| "exclusive breastfeeding" group | – | Other: data collectionWomen initiating exclusive breastfeeding after birth |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Age groups
- Adult, Older adult
- Study population
- Mother initiating exclusive breastfeeding after birth
Key inclusion criteria (4 listed)
- primiparous and multiparous women
- women who have initiate breastfeeding
- women aged 18 and more
- agreeing to participate in the study
Key exclusion criteria (2 listed)
- women whose newborn has been in intensive care unit
- women with a multiple pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| data collectioncontinuation of exclusive breastfeeding until the post-natal visit (6 to 8 weeks after birth) | Other | "exclusive breastfeeding" group |
Primary outcome
breastfeeding
Time frame: Day 0
number of women practicing or not exclusive breastfeeding until postnatal consultation (6 to 8 weeks after birth)
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Dec 2022.
Related trials for Breastfeeding
RecruitingObservational study
Improving Nutrition for Babies Born by Caesarean Section
Breastfeeding Mothers of Legal Age, Their Babies Under 6 Months Old Born Vaginally
RecruitingPhase 4
A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
Lactation, Inflammatory Bowel Disease
Enrolling by invitation
Development and Implementation of a Breastfeeding Program for Post-Cesarean Section Women Based on the 5A Nursing Model
Breastfeeding Rates
RecruitingPhase 4
A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Psoriasis, Colitis, Ulcerative
Not yet recruiting
The Effect of Music Play and Stress Ball Application on Placental Separation Time, Episious Pain and Breastfeeding Success
Primiparity (First-Time Mothers), Breastfeeding
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Questions about this trial
What is this clinical trial studying?
An observational study of Breastfeeding, run by Université de Reims Champagne-Ardenne.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 16 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact CURRS CURRS (0326918822, currs@univ-reims.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
breastfeeding (time frame: Day 0). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Dec 2022.